Alzheimer's vs. dementia: An overview for National Alzheimer's Disease Awareness Month

While there are many conditions that can cause memory loss, dementia and Alzheimer’s disease are probably two of the most well-known terms associated with cognitive decline. However, while these two terms are often used interchangeably, they actually refer to different kinds of memory loss diseases. In honor of November being National Alzheimer’s Disease Awareness Month, we wanted to take a few ...

Continue reading

OneStudyTeam and Antidote are partnering to maximize clinical trial recruitment and enrollment

We are excited to announce our new partnership with OneStudyTeam, a company that provides the cloud-based platform StudyTeam™ to connect site and sponsor workflows. By combining our complementary technology, this partnership will provide sites and sponsors with a connected, end-to-end patient referral management experience.

Continue reading

Antidote Technologies and Beyond Celiac Partner to Match Celiac Patients with Research Opportunities

We’re thrilled to share that today, we announced an important collaboration with Beyond Celiac, the leading celiac disease organization working to drive diagnosis, advance research, and accelerate the discovery of new treatments and a cure. We’ve been working with this incredible organization to make our celiac disease clinical trial search even better for patients and caregivers — and we’re now ...

Continue reading

15 questions to ask clinical trial recruitment companies

Clinical trial patient recruitment companies implement a range of methods, from digital advertising to community partnerships, to reach patients that might be a good fit for a study — but because there are many options for companies to work with, it is important that sites and sponsors thoroughly evaluate their options and choose the right vendor for their needs.

Continue reading

How to get the most out of Antidote Match™

At Antidote, our mission is to connect patients with clinical trials using a data-driven, technological approach — and one of the ways we do that is through our clinical trial search engine, Antidote Match™.

Continue reading

Antidote’s database by the numbers [infographic]

We often reference our patient database: 400,000+ patients who have raised their hands to take part in medical research and shared health data to help us determine eligibility. The beauty of the Antidote database is that it provides a real-word picture of true patient populations — their demographic information as well as health details such as conditions they have, medications they’re on, and ...

Continue reading

What is IgA nephropathy?

IgA nephropathy, also known as Berger’s disease, refers to a buildup of protein in the kidneys that causes inflammation and damage. It is a chronic kidney disease that progresses over 10 to 20 years and can eventually lead to kidney failure. 

Continue reading

User acquisition through partnership [one-pager]

The app marketplace is competitive, especially in the health and wellness sector, making user acquisition a considerable challenge. Successful app outreach requires strategic targeting and smart technology to appeal to users — and Antidote can provide these solutions. Our patient recruitment expertise translates well to assisting apps with building out their user base. 

Continue reading

How do I become a medical studies participant?

Throughout history, clinical trials have been an important element in learning about new drugs and treatments — but without patient participation, the medical remedies that are so ubiquitous in our lives today would not exist. Because it’s required for all drugs to go through testing before they are released on the market, volunteers for clinical trials have a major impact on medical research as ...

Continue reading

Webinar recap: Lung Cancer Initiative webinar featuring Rich Towne

On October 4, Antidote’s Senior Clinical Informatics Manager Dr. Rich Towne participated in a community education webinar for the North Carolina chapter of Lung Cancer Initiative. This webinar was aimed at educating lung cancer patients and professionals in the lung cancer industry on clinical trials and recent advancements in the field.

Continue reading

Get our latest posts in your inbox